{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:04:15Z","timestamp":1794002655710,"version":"4.8.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T00:00:00Z","timestamp":1687996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although there is numerous evidence on the epidemiological risk factors for insulin resistance (IR)-related metabolic diseases, there is still insufficient evidence to explore the non-linear association of Atherogenic Index of Plasma (AIP) with IR. Therefore, we aimed to elucidate the non-linear relationship between AIP and IR and type 2 diabetes (T2D).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study was conducted in the National Health and Nutrition Survey (NHANES) from 2009 to 2018. A total of 9,245 participants were included in the study. The AIP was calculated as log10 (triglycerides\/high-density lipoprotein cholesterol). The outcome variables included IR and T2D defined by the 2013 American Diabetes Association guidelines. The weighted multivariate linear regression, weighted multivariate logistic regression, subgroup analysis, generalized additive model, smooth fitting curve and two-part logistic regression were adopted to reveal the relationship of AIP with IR and T2D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>After adjustment for age, gender, race, education level, smoking status, alcohol consumption, vigorous\/moderate physical activity, body mass index, waist circumference and hypertension, we found that AIP was positively associated with fasting blood glucose (\u03b2\u2009=\u20090.08, 95% CI: 0.06, 0.10), glycosylated hemoglobin (\u03b2\u2009=\u20090.04, 95% CI: 0.39, 0.58), fasting serum insulin (\u03b2\u2009=\u20094.26, 95% CI: 3.73, 4.79), and homeostasis model assessment of insulin resistance (\u03b2\u2009=\u20090.22, 95% CI: 0.18, 0.25). Further studies found that AIP was associated with increased risk of IR (OR\u2009=\u20091.29, 95% CI: 1.26\u20131.32) and T2D (OR\u2009=\u20091.18, 95% CI: 1.15\u20131.22). However, the positive association between AIP and IR or T2D was more significant in female than in male (IR: P for interaction\u2009=\u20090.0135; T2D: P for interaction\u2009=\u20090.0024). A non-linear and inverse L-shaped association was found between AIP and IR, while a J-shaped association was found between AIP and T2D. In patients with \u2212\u20090.47\u2009&lt;\u2009AIP\u2009&lt;\u20090.45, increased AIP was significantly associated with increased risk of IR and T2D.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>AIP showed an inverse L-shaped association with IR and a J-shaped association with T2D, indicating that AIP should be reduced to a certain level to prevent IR and T2D.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12933-023-01886-5","type":"journal-article","created":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T13:02:00Z","timestamp":1688043720000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":240,"title":["Non-linear association of atherogenic index of plasma with insulin resistance and type 2 diabetes: a cross-sectional study"],"prefix":"10.1186","volume":"22","author":[{"given":"Bei","family":"Yin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqing","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunqiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,29]]},"reference":[{"issue":"5","key":"1886_CR1","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cjca.2017.12.007","volume":"34","author":"P Stahel","year":"2018","unstructured":"Stahel P, Xiao C, Hegele RA, Lewis GF. The atherogenic Dyslipidemia Complex and Novel Approaches to Cardiovascular Disease Prevention in Diabetes. Can J Cardiol. 2018;34(5):595\u2013604.","journal-title":"Can J Cardiol"},{"key":"1886_CR2","doi-asserted-by":"crossref","unstructured":"Ivanova EA, Myasoedova VA, Melnichenko AA, Grechko AV, Orekhov AN. Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases. Oxid Med Cell Longev. 2017; 2017:1273042.","DOI":"10.1155\/2017\/1273042"},{"issue":"1","key":"1886_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12944-017-0545-z","volume":"16","author":"J Liu","year":"2017","unstructured":"Liu J, Yang R, Zhou M, Mao W, Li H, Zhao H, Wang S, Chen W, Dong J, He Q. Fractional esterification rate of cholesterol in high-density lipoprotein associates with risk of coronary heart disease. Lipids Health Dis. 2017;16(1):162.","journal-title":"Lipids Health Dis"},{"issue":"7","key":"1886_CR4","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S0009-9120(01)00263-6","volume":"34","author":"M Dobi\u00e1sov\u00e1","year":"2001","unstructured":"Dobi\u00e1sov\u00e1 M, Frohlich J. The plasma parameter log (TG\/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apob-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583\u20138.","journal-title":"Clin Biochem"},{"issue":"5","key":"1886_CR5","doi-asserted-by":"publisher","first-page":"e42821","DOI":"10.1136\/bmjopen-2020-042821","volume":"11","author":"J Peng","year":"2021","unstructured":"Peng J, Zhao F, Yang X, Pan X, Xin J, Wu M, Peng YG. Association between dyslipidemia and risk of type 2 diabetes mellitus in middle-aged and older chinese adults: a secondary analysis of a nationwide cohort. Bmj Open. 2021;11(5):e42821.","journal-title":"Bmj Open"},{"issue":"7","key":"1886_CR6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/pedi.12890","volume":"20","author":"H Manell","year":"2019","unstructured":"Manell H, Kristinsson H, Kullberg J, Ubhayasekera S, M\u00f6rwald K, Staaf J, Cadamuro J, Zsoldos F, G\u00f6pel S, Sargsyan E, et al. Hyperglucagonemia in youth is associated with high plasma free fatty acids, visceral adiposity, and impaired glucose tolerance. Pediatr Diabetes. 2019;20(7):880\u201391.","journal-title":"Pediatr Diabetes"},{"issue":"7","key":"1886_CR7","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.2337\/diabetes.50.7.1612","volume":"50","author":"G Boden","year":"2001","unstructured":"Boden G, Lebed B, Schatz M, Homko C, Lemieux S. Effects of acute changes of plasma free fatty acids on intramyocellular fat content and insulin resistance in healthy subjects. Diabetes. 2001;50(7):1612\u20137.","journal-title":"Diabetes"},{"key":"1886_CR8","doi-asserted-by":"crossref","unstructured":"Di Bartolo BA, Cartland SP, Genner S, Manuneedhi CP, Vellozzi M, Rye KA, Kavurma MM. HDL Improves Cholesterol and Glucose Homeostasis and Reduces Atherosclerosis in Diabetes-Associated Atherosclerosis. J Diabetes Res. 2021; 2021:6668506.","DOI":"10.1155\/2021\/6668506"},{"issue":"6","key":"1886_CR9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.18097\/PBMC20186406463","volume":"64","author":"ON Poteryaeva","year":"2018","unstructured":"Poteryaeva ON, Usynin IF. [Antidiabetic role of high density lipoproteins]. Biomed Khim. 2018;64(6):463\u201371.","journal-title":"Biomed Khim"},{"issue":"5","key":"1886_CR10","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.arcmed.2019.08.009","volume":"50","author":"JC Fern\u00e1ndez-Mac\u00edas","year":"2019","unstructured":"Fern\u00e1ndez-Mac\u00edas JC, Ochoa-Mart\u00ednez AC, Varela-Silva JA, P\u00e9rez-Maldonado IN. Atherogenic index of plasma: Novel Predictive Biomarker for Cardiovascular Illnesses. Arch Med Res. 2019;50(5):285\u201394.","journal-title":"Arch Med Res"},{"issue":"1","key":"1886_CR11","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12944-018-0656-1","volume":"17","author":"SW Shen","year":"2018","unstructured":"Shen SW, Lu Y, Li F, Yang CJ, Feng YB, Li HW, Yao WF, Shen ZH. Atherogenic index of plasma is an effective index for estimating abdominal obesity. Lipids Health Dis. 2018;17(1):11.","journal-title":"Lipids Health Dis"},{"key":"1886_CR12","doi-asserted-by":"crossref","unstructured":"Zhang JS, Yeh WC, Tsai YW, Chen JY. The relationship between Atherogenic Index of plasma and obesity among adults in Taiwan. Int J Env Res Pub He. 2022; 19(22).","DOI":"10.3390\/ijerph192214864"},{"issue":"1","key":"1886_CR13","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12933-023-01740-8","volume":"22","author":"Y Shi","year":"2023","unstructured":"Shi Y, Wen M. Sex-specific differences in the effect of the atherogenic index of plasma on prediabetes and diabetes in the NHANES 2011\u20132018 population. Cardiovasc Diabetol. 2023;22(1):19.","journal-title":"Cardiovasc Diabetol"},{"issue":"2","key":"1886_CR14","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00592-021-01801-y","volume":"59","author":"Q Yi","year":"2022","unstructured":"Yi Q, Ren Z, Bai G, Zhu S, Li S, Li C, Wu H, Zhu Y, Song P. The longitudinal effect of the atherogenic index of plasma on type 2 diabetes in middle-aged and older chinese. Acta Diabetol. 2022;59(2):269\u201379.","journal-title":"Acta Diabetol"},{"issue":"1","key":"1886_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.pcd.2014.03.007","volume":"9","author":"XW Zhu","year":"2015","unstructured":"Zhu XW, Deng FY, Lei SF. Meta-analysis of Atherogenic Index of plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus. Prim Care Diabetes. 2015;9(1):60\u20137.","journal-title":"Prim Care Diabetes"},{"issue":"1","key":"1886_CR16","doi-asserted-by":"publisher","first-page":"9900","DOI":"10.1038\/s41598-021-89307-z","volume":"11","author":"YW Li","year":"2021","unstructured":"Li YW, Kao TW, Chang PK, Chen WL, Wu LW. Atherogenic index of plasma as predictors for metabolic syndrome, hypertension and diabetes mellitus in Taiwan citizens: a 9-year longitudinal study. Sci Rep-Uk. 2021;11(1):9900.","journal-title":"Sci Rep-Uk"},{"issue":"7","key":"1886_CR17","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1373\/clinchem.2004.031757","volume":"50","author":"MH Tan","year":"2004","unstructured":"Tan MH, Johns D, Glazer NB. Pioglitazone reduces atherogenic index of plasma in patients with type 2 diabetes. Clin Chem. 2004;50(7):1184\u20138.","journal-title":"Clin Chem"},{"key":"1886_CR18","doi-asserted-by":"publisher","first-page":"160096","DOI":"10.1038\/sdata.2016.96","volume":"3","author":"CJ Patel","year":"2016","unstructured":"Patel CJ, Pho N, Mcduffie M, Easton-Marks J, Kothari C, Kohane IS, Avillach P. A database of human exposomes and phenomes from the US National Health and Nutrition Examination Survey. Sci Data. 2016;3:160096.","journal-title":"Sci Data"},{"issue":"190","key":"1886_CR19","first-page":"1","volume":"1","author":"LJ Akinbami","year":"2022","unstructured":"Akinbami LJ, Chen TC, Davy O, Ogden CL, Fink S, Clark J, Riddles MK, Mohadjer LK. National Health and Nutrition Examination Survey, 2017-March 2020 Prepandemic file: Sample Design, Estimation, and Analytic Guidelines. Vital Health Stat. 2022;1(190):1\u201336.","journal-title":"Vital Health Stat"},{"issue":"160","key":"1886_CR20","first-page":"1","volume":"2","author":"LR Curtin","year":"2013","unstructured":"Curtin LR, Mohadjer LK, Dohrmann SM, Kruszon-Moran D, Mirel LB, Carroll MD, Hirsch R, Burt VL, Johnson CL. National Health and Nutrition Examination Survey: sample design, 2007\u20132010. Vital Health Stat. 2013;2(160):1\u201323.","journal-title":"Vital Health Stat"},{"issue":"56","key":"1886_CR21","first-page":"1","volume":"1","author":"G Zipf","year":"2013","unstructured":"Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999\u20132010. Vital Health Stat. 2013;1(56):1\u201337.","journal-title":"Vital Health Stat"},{"key":"1886_CR22","doi-asserted-by":"publisher","first-page":"890273","DOI":"10.3389\/fendo.2022.890273","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Liu F, Kong R, Han X. Association between Globulin and Diabetic Nephropathy in Type2 Diabetes Mellitus Patients: a cross-sectional study. Front Endocrinol. 2022;13:890273.","journal-title":"Front Endocrinol"},{"issue":"2","key":"1886_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.2337\/dc21-1674","volume":"45","author":"S Wang","year":"2022","unstructured":"Wang S, Wang Y, Wan X, Guo J, Zhang Y, Tian M, Fang S, Yu B. Cobalamin Intake and related biomarkers: Examining Associations with mortality risk among adults with type 2 diabetes in NHANES. Diabetes Care. 2022;45(2):276\u201384.","journal-title":"Diabetes Care"},{"issue":"6","key":"1886_CR24","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","volume":"27","author":"TM Wallace","year":"2004","unstructured":"Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487\u201395.","journal-title":"Diabetes Care"},{"key":"1886_CR25","doi-asserted-by":"publisher","first-page":"735736","DOI":"10.3389\/fendo.2021.735736","volume":"12","author":"Y Liu","year":"2021","unstructured":"Liu Y, Gong R, Luo G, Li J, Li Q, Yang L, Wei X. Associations of Triglycerides\/High-Density lipoprotein cholesterol ratio with insulin resistance, impaired glucose tolerance, and diabetes in american adults at different vitamin D3 levels. Front Endocrinol. 2021;12:735736.","journal-title":"Front Endocrinol"},{"issue":"Suppl 1","key":"1886_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2337\/dc13-S011","volume":"36","author":"AD Association","year":"2013","unstructured":"Association AD. Standards of medical care in diabetes\u20132013. Diabetes Care. 2013;36(Suppl 1):11\u2013S66.","journal-title":"Diabetes Care"},{"issue":"6","key":"1886_CR27","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1097\/EDE.0b013e3181577511","volume":"18","author":"JP Vandenbroucke","year":"2007","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, G\u00f8tzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M. Strengthening the reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Epidemiology. 2007;18(6):805\u201335.","journal-title":"Epidemiology"},{"issue":"9","key":"1886_CR28","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1001\/jama.2014.10432","volume":"312","author":"RF Kushner","year":"2014","unstructured":"Kushner RF, Ryan DH. Assessment and lifestyle management of patients with obesity: clinical recommendations from systematic reviews. Jama-J Am Med Assoc. 2014;312(9):943\u201352.","journal-title":"Jama-J Am Med Assoc"},{"issue":"3","key":"1886_CR29","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/ijo.2009.2","volume":"33","author":"AM Sharma","year":"2009","unstructured":"Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obesity. 2009;33(3):289\u201395.","journal-title":"Int J Obesity"},{"issue":"1","key":"1886_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13098-021-00645-4","volume":"13","author":"AL Missel","year":"2021","unstructured":"Missel AL, Saslow LR, Griauzde DH, Marvicsin D, Sen A, Richardson CR, Liu X. Association between fasting insulin and C-reactive protein among adults without diabetes using a two-part model: NHANES 2005\u20132010. Diabetol Metab Syndr. 2021;13(1):29.","journal-title":"Diabetol Metab Syndr"},{"issue":"11","key":"1886_CR31","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1530\/EC-21-0414","volume":"10","author":"R Gong","year":"2021","unstructured":"Gong R, Luo G, Wang M, Ma L, Sun S, Wei X. Associations between TG\/HDL ratio and insulin resistance in the US population: a cross-sectional study. Endocr Connect. 2021;10(11):1502\u201312.","journal-title":"Endocr Connect"},{"key":"1886_CR32","doi-asserted-by":"crossref","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DJ, Collins KJ, Dennison HC, Depalma SM, Gidding S, Jamerson KA, Jones DW, ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH et al. \/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018; 71(6):e13-e115.","DOI":"10.1161\/HYP.0000000000000065"},{"issue":"161","key":"1886_CR33","first-page":"1","volume":"2","author":"CL Johnson","year":"2013","unstructured":"Johnson CL, Paulose-Ram R, Ogden CL, Carroll MD, Kruszon-Moran D, Dohrmann SM, Curtin LR. National health and nutrition examination survey: analytic guidelines, 1999\u20132010. Vital Health Stat. 2013;2(161):1\u201324.","journal-title":"Vital Health Stat"},{"issue":"2","key":"1886_CR34","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jacl.2010.02.005","volume":"4","author":"A Onat","year":"2010","unstructured":"Onat A, Can G, Kaya H, Hergen\u00e7 G. Atherogenic index of plasma\u201d (log10 triglyceride\/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol. 2010;4(2):89\u201398.","journal-title":"J Clin Lipidol"},{"issue":"4","key":"1886_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.metabol.2011.09.009","volume":"61","author":"D Gasevic","year":"2012","unstructured":"Gasevic D, Frohlich J, Mancini GB, Lear SA. The association between triglyceride to high-density-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort. Metabolism. 2012;61(4):583\u20139.","journal-title":"Metabolism"},{"issue":"2","key":"1886_CR36","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.metabol.2009.07.027","volume":"59","author":"SJ Kim-Dorner","year":"2010","unstructured":"Kim-Dorner SJ, Deuster PA, Zeno SA, Remaley AT, Poth M. Should triglycerides and the triglycerides to high-density lipoprotein cholesterol ratio be used as surrogates for insulin resistance? Metabolism. 2010;59(2):299\u2013304.","journal-title":"Metabolism"},{"issue":"6","key":"1886_CR37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1089\/met.2010.0028","volume":"8","author":"AE Sumner","year":"2010","unstructured":"Sumner AE, Harman JL, Buxbaum SG, Miller BR, Tambay AV, Wyatt SB, Taylor HA, Rotimi CN, Sarpong DF. The triglyceride\/high-density lipoprotein cholesterol ratio fails to predict insulin resistance in african-american women: an analysis of Jackson Heart Study. Metab Syndr Relat D. 2010;8(6):511\u20134.","journal-title":"Metab Syndr Relat D"},{"issue":"7","key":"1886_CR38","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/1753-0407.12477","volume":"9","author":"YL Wang","year":"2017","unstructured":"Wang YL, Koh WP, Talaei M, Yuan JM, Pan A. Association between the ratio of triglyceride to high-density lipoprotein cholesterol and incident type 2 diabetes in Singapore chinese men and women. J Diabetes. 2017;9(7):689\u201398.","journal-title":"J Diabetes"},{"issue":"3","key":"1886_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/1753-0407.12836","volume":"11","author":"C Cheng","year":"2019","unstructured":"Cheng C, Liu Y, Sun X, Yin Z, Li H, Zhang M, Zhang D, Wang B, Ren Y, Zhao Y, et al. Dose-response association between the triglycerides: high-density lipoprotein cholesterol ratio and type 2 diabetes mellitus risk: the rural chinese cohort study and meta-analysis. J Diabetes. 2019;11(3):183\u201392.","journal-title":"J Diabetes"},{"issue":"1","key":"1886_CR40","doi-asserted-by":"publisher","first-page":"e116110","DOI":"10.1371\/journal.pone.0116110","volume":"10","author":"L Zhang","year":"2015","unstructured":"Zhang L, Chen S, Deng A, Liu X, Liang Y, Shao X, Sun M, Zou H. Association between lipid ratios and insulin resistance in a chinese population. PLoS ONE. 2015;10(1):e116110.","journal-title":"PLoS ONE"},{"issue":"12","key":"1886_CR41","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/j.amjcard.2012.02.016","volume":"109","author":"MR Salazar","year":"2012","unstructured":"Salazar MR, Carbajal HA, Espeche WG, Leiva SC, Balb\u00edn E, Dulbecco CA, Aizpur\u00faa M, Marillet AG, Reaven GM. Relation among the plasma triglyceride\/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardio-metabolic risk factors in men and women. Am J Cardiol. 2012;109(12):1749\u201353.","journal-title":"Am J Cardiol"},{"key":"1886_CR42","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1476-511X-9-85","volume":"9","author":"F Hadaegh","year":"2010","unstructured":"Hadaegh F, Hatami M, Tohidi M, Sarbakhsh P, Saadat N, Azizi F. Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of iranian men and women. Lipids Health Dis. 2010;9:85.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"1886_CR43","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.jdiacomp.2018.10.018","volume":"33","author":"KA Young","year":"2019","unstructured":"Young KA, Maturu A, Lorenzo C, Langefeld CD, Wagenknecht LE, Chen YI, Taylor KD, Rotter JI, Norris JM, Rasouli N. The triglyceride to high-density lipoprotein cholesterol (TG\/HDL-C) ratio as a predictor of insulin resistance, \u03b2-cell function, and diabetes in Hispanics and African Americans. J Diabetes Complicat. 2019;33(2):118\u201322.","journal-title":"J Diabetes Complicat"},{"issue":"8","key":"1886_CR44","doi-asserted-by":"publisher","first-page":"7622","DOI":"10.3390\/ijerph110807622","volume":"11","author":"L Zhang","year":"2014","unstructured":"Zhang L, Yuan Z, Chen W, Chen S, Liu X, Liang Y, Shao X, Zou H. Serum lipid profiles, lipid ratios and chronic kidney disease in a chinese population. Int J Env Res Pub He. 2014;11(8):7622\u201335.","journal-title":"Int J Env Res Pub He"},{"issue":"1","key":"1886_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1530\/JOE-11-0044","volume":"212","author":"MH Faulds","year":"2012","unstructured":"Faulds MH, Zhao C, Dahlman-Wright K, Gustafsson J. The diversity of sex steroid action: regulation of metabolism by estrogen signaling. J Endocrinol. 2012;212(1):3\u201312.","journal-title":"J Endocrinol"},{"issue":"1","key":"1886_CR46","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12933-022-01531-7","volume":"21","author":"T Yang","year":"2022","unstructured":"Yang T, Liu Y, Li L, Zheng Y, Wang Y, Su J, Yang R, Luo M, Yu C. Correlation between the triglyceride-to-high-density lipoprotein cholesterol ratio and other unconventional lipid parameters with the risk of prediabetes and type 2 diabetes in patients with coronary heart disease: a RCSCD-TCM study in China. Cardiovasc Diabetol. 2022;21(1):93.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01886-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-01886-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-01886-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T14:02:41Z","timestamp":1688047361000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-01886-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,29]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1886"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-01886-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2799078\/v1","asserted-by":"object"}]},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,29]]},"assertion":[{"value":"10 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The NHANES protocol was revised, approved by the Ethics Review Committee of the National Center for Health Statistics.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients\/participants provided their written informed consent to participate in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"157"}}